Publicly listed (IPO) on Taipei Exchange, stock ticker: 6499
U.S. Food and Drug Administration 510(k) clearance for AbClose™(LAP-C01) Trocar Wound Closure Device
Invested in Prodeon to develop the Mercury Project (URO-T01) for treatment of Benign Prostatic Hyperplasia (BPH)
Invested in Delta Asia International Co. to enrich manufacturing capability